Abiopharma

🔍 Voss Capital, LP (Executive)

Company: Flywire Corp (FLYW)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Sold 2,154 shares of Voting common stock, $0.0001 par value per share at $19.4887 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 372,846.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
• Sold 3,678 shares of Voting common stock, $0.0001 par value per share at $19.1941 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 369,168.00 | transaction_form_type: 4 | Footnotes: F1, F7, F3
• Sold 99,146 shares of Voting common stock, $0.0001 par value per share at $19.4886 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,400,854.00 | transaction_form_type: 4 | Footnotes: F1, F8, F4
• Sold 169,295 shares of Voting common stock, $0.0001 par value per share at $19.1941 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,231,559.00 | transaction_form_type: 4 | Footnotes: F1, F9, F4
• Holds 0 shares of Voting common stock, $0.0001 par value per share (Direct)
  Date: 2026-08-24 | Code: H | nature_of_ownership: By: Voss Value Master Fund, L.P. | shares_owned_after: 2,250,000.00 | Footnotes: F1, F2
• Holds 100,000 shares of Call Option (right to buy) at $10.0 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2026-09-18 | shares_owned_after: 1,000.00 | Footnotes: F5, F1, F4
• Holds 50,000 shares of Call Option (right to buy) at $7.5 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2026-12-18 | shares_owned_after: 500.00 | Footnotes: F5, F1, F4

Footnotes:

• F1: This Form 4 is filed jointly by Voss Value Master Fund, LP ("Voss Value Master Fund"), Voss Value-Oriented Special Situations Fund, LP ("Voss Value-Oriented Special Situations Fund"), Voss Advisors GP, LLC ("Voss GP"), Voss Capital, LP ("Voss Capital") and Travis W. Cocke (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
• F2: Securities owned directly by Voss Value Master Fund. Voss GP, as the general partner of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Voss Capital, as the investment manager of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund.
• F3: Securities owned directly by Voss Value-Oriented Special Situations Fund. Voss GP, as the general partner of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Voss Capital, as the investment manager of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund.
• F4: Securities held in certain accounts separately managed by Voss Capital (the "Voss Managed Accounts"). Voss Capital, as the investment manager of the Voss Managed Accounts, may be deemed to beneficially own the securities held in the Voss Managed Accounts. Mr. Cocke, as the managing member of Voss Capital, may be deemed to beneficially own the securities held in the Voss Managed Accounts.
• F5: Such call options were immediately exercisable upon their acquisition.
• F6: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.4868 to $19.63, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F7: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.1776 to $19.2136, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F8: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.4868 to $19.63, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F9: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.1776 to $19.2136, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.